L

Labiana Health SA
MAD:LAB

Watchlist Manager
Labiana Health SA
MAD:LAB
Watchlist
Price: 3.06 EUR 0.66% Market Closed
Market Cap: 22.1m EUR
LAB
/
Income Statement
/
Revenue

Labiana Health SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Labiana Health SA
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
L
Labiana Health SA
MAD:LAB
Revenue
€66.3m
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Almirall SA
MAD:ALM
Revenue
€985.7m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
2%
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Revenue
€763.7m
CAGR 3-Years
6%
CAGR 5-Years
15%
CAGR 10-Years
12%
F
Faes Farma SA
MAD:FAE
Revenue
€493.6m
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
10%
Laboratorio Reig Jofre SA
MAD:RJF
Revenue
€338.9m
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
19%

Labiana Health SA
Glance View

Market Cap
21.2m EUR
Industry
Pharmaceuticals

Labiana Health SA manufactures sterile and lyophilized dosage forms. The company is headquartered in Pozuelo De Alarcon, Madrid and currently employs 477 full-time employees. The company went IPO on 2022-06-24. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.

LAB Intrinsic Value
16.8 EUR
Undervaluation 82%
Intrinsic Value
Price
L
What is Intrinsic Value?

See Also

What is Labiana Health SA's Revenue?
Revenue
66.3m EUR

Based on the financial report for Dec 31, 2024, Labiana Health SA's Revenue amounts to 66.3m EUR.

What is Labiana Health SA's Revenue growth rate?
Revenue CAGR 5Y
6%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Labiana Health SA have been 5% over the past three years , 6% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 250,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.